Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7010717 | 0.86 | ITGB3 (0.58) | ITGB3ITGA2B | |
| SCHEMBL7782706 | 0.86 | ITGB3 (0.59) | ITGB3ITGA2B | |
| SCHEMBL7019568 | 0.83 | ITGB3 (0.73) | ITGB3ITGA2B | |
| SCHEMBL7013014 | 0.83 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL7006823 | 0.82 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL7008270 | 0.81 | ITGB3 (0.78) | ITGB3ITGA2B | |
| SCHEMBL484916 | 0.75 | ITGB3 (0.68) | ITGB3ITGA2B | |
| SCHEMBL7013026 | 0.75 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL7790309 | 0.75 | ITGB3 (0.57) | ITGB3ITGA2B | |
| SCHEMBL7393626 | 0.74 | ITGB3 (0.57) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030055244-A1 | Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation | MILLENNIUM PHARMACEUTICALS, INC. | 2003-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055244-A1 | Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation | PF4, PFKP, FGB | ITGB3 139/4885ITGA2B 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.